Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ASLAN PHARMACEU/ADRQ BioMedCNS PharmaceuticalsSCYNEXISLeap Therapeutics
SymbolNASDAQ:ASLNOTCMKTS:QBIONASDAQ:CNSPNASDAQ:SCYXNASDAQ:LPTX
Price Information
Current Price$0.97$2.25$2.16$0.81$1.42
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$6.33N/AN/A$4.63$3.67
% Upside from Price Target556.03% upsideN/AN/A470.99% upside158.22% upside
Trade Information
Market Cap$32.37 million$47.01 million$31.42 million$75.01 million$49.76 million
Beta2.83.52N/A1.821.7
Average Volume154,251173,79481,780692,280298,355
Sales & Book Value
Annual Revenue$3 millionN/AN/A$120,000.00N/A
Price / Sales10.31N/AN/A657.59N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.02) per share($0.26) per share$0.48 per share$0.13 per share($0.07) per share
Price / Book-48.27N/AN/A6.23N/A
Profitability
Net Income$-47,070,000.00$-10,280,000.00$-3,880,000.00$-53,710,000.00$-32,900,000.00
EPS($0.74)N/AN/A($0.81)($1.47)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-167.07%N/AN/A-443.94%-413.63%
Return on Assets (ROA)-67.33%-1,047.91%N/A-102.19%-194.07%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.12%N/AN/A1.15%0.12%
Current Ratio4.14%0.04%25.38%4.76%0.50%
Quick RatioN/A0.04%25.38%4.76%0.50%
Ownership Information
Institutional Ownership Percentage10.28%0.01%0.57%68.27%13.70%
Insider Ownership PercentageN/AN/AN/A5.56%35.40%
Miscellaneous
EmployeesN/A1N/A2423
Shares Outstanding32.05 million20.90 million15.71 million97.42 million35.80 million
Next Earnings Date5/4/2020 (Estimated)4/15/2020 (Estimated)6/11/2020 (Estimated)5/13/2020 (Estimated)5/20/2020 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel